NCT06608849 - The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19 | Biotech Hunter

Enrollment

345

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

November 4, 2027

Study Completion Date

November 4, 2027

Conditions

Pulmonary ComplicationsCardiovascular ComplicationsRenal ComplicationsCOVID-19

Interventions

OTHER

Blood samples

Blood sampling for proteomics and transcriptomics, suPAR measurement \& isolation and stimulation of peripheral blood mononuclear cells, eGFR, serum creatinine, cystatin c \& urea

OTHER

Six-minute walk test, Spirometry, HRCT, Heart ultrasound, Completion of questionnaires of symptoms

Spirometry for forced expiratory volume in the first, second, total lung capacity and diffusion capacity of carbon monoxide.

Trial Locations (6)

Unknown

RECRUITING

10th Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest Diseases, Athens

RECRUITING

4th Department of Internal Medicine, ATTIKON University General Hospital, Athens

RECRUITING

Obstructive Diseases Clinic, Sotiria Athens Hospital of Chest Diseases, Athens

RECRUITING

Out-patient department of Infectious Diseases, Sotiria Athens Hospital of Chest Diseases, Athens

RECRUITING

1st Department of Internal Medicine, Thriasio General Hospital of Elefsina, Elefsina

RECRUITING

2nd Department of Internal Medicine, Thriasio General Hospital of Elefsina, Elefsina

All Listed Sponsors

lead

Hellenic Institute for the Study of Sepsis

OTHER